http://www.thehindu.com/news/cities/Hyderabad/Aurobindo-Pharma-gets-USFDA-nod/article13994584.ece

Aurobindo Pharma Ltd has received USFDA approval to manufacture and market Norethindrone Acetate tablets USP 5 mg, which is used in the treatment of endometriosis, uterine bleeding caused by abnormal hormone levels and secondary amenorrhea.The approved ANDA is bioequivalent and therapeutically equivalent to the reference listed drug product Aygestin tablets 5 mg of Duramed Pharmaceuticals, according to a regulatory filing by Aurobindo Pharma on Monday. The approved product has an estimated market of $ 24 million for the twelve months ended November 2015, the company said citing IMS figures.